On September 15, 2022, Absci Corporation and Nikhil Goel, the Company's Chief Strategy Officer, agreed that Mr. Goel's employment with the Company would end effective as of September 20, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | +0.98% | +1.99% | -26.67% |
06-10 | Absci Seeks M&A Opportunity | CI |
06-10 | Transcript : Absci Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 02:00 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.67% | 348M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- ABSI Stock
- News Absci Corporation
- Absci Corporation Announces End of Nikhil Goel as Chief Strategy Officer